COVID-19, SIXTEEN MONTHS INTO THE PANDEMIC: A NARRATIVE REVIEW
Keywords:
Keywords: COVID-19 overview, COVID-19 management, critical care, respiratory failureAbstract
COVID-19, the disease caused by the newly-discovered SARS-CoV-2 virus, has quickly spread from China throughout the world since January 2020. Its potential severity, despite in a minority of cases, has paralysed healthcare systems struggling for adequate resources, as well as entire nations often forced to adopt radical measures, such as lockdowns and surveillance, to contain the disease and restrict its spread. Initially presenting as a respiratory infectious disease, it can not only progress to an acute respiratory distress syndrome, but also have multisystemic consequences. There are many proving theories as regards to the pathophysiology and there are currently no proven definitive treatments. Due to its high transmissibility and the risk of infecting healthcare workers, hospitals also had to rethink their organisation. We have completed a literature review of the sixteen months of the pandemic, with attention to pathophysiology, key epidemiological concepts, hospital organisation, critical care considerations, and finally current and prospective treatments.References
WHO. World Health Organization Timeline - COVID-19. 2020. [Internet]. [cited 2020 June 4]. Available from: https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19
Worldometers.info. 2020. Coronavirus Update (Live): 6,789,402 Cases And 396,192 Deaths From COVID-19 Virus Pandemic. [Internet]. [cited 2020 June 4]. Available from: https://www.worldometers.info/coronavirus/
Rehill N. COVID-19: a synthesis of clinical experience in UK intensive care settings. [cited 2020 June 10]. Available from: https://renal.org/wp-content/uploads/2020/04/COVID-19_synthesis-of-clinical-experience-in-UK-intensive-care_04.04.2020_FINAL.pdf
Brainard J. Scientists are drowning in COVID-19 papers. Can new tools keep them afloat? Science 2020;12:15.
Coren MJ. The number of scientific papers on the novel coronavirus is doubling every 14 days. [cited 2020 June 10]. Available from: https://qz.com/1834521/scientific-papers-on-novel-coronavirus-doubling-every-14-days/
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579(7798):270–3.
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med 2020;26(4):450–2.
Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631–7.
Ma J. Coronavirus: China’s first confirmed Covid-19 case traced back to November 17. South China Morning Post, 2020. [cited 2020 June 10]. Available from: https://www.scmp.com/news/china/society/article/3074991/coronavirus-chinas-first-confirmed-covid-19-case-traced-back
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020382(13):1199–1207.
Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis 2020;20(5):553–8.
Pung R, Chiew CJ, Young BE, Chin S, Chen MI, Clapham HE, et al. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures. Lancet 2020;395(10229):1039–46.
Ceylan Z. Estimation of COVID-19 prevalence in Italy, Spain, and France. Sci Total Environ 2020;729:138817.
Zastrow M. South Korea is reporting intimate details of COVID-19 cases: has it helped? Nature 2020;12:15.
Douglas J, Mendes FK, Bouckaert R, Xie D, Jiménez-Silva CL, Swanepoel C, de Ligt J, Ren X, Storey M, Hadfield J, Simpson CR. Phylodynamics reveals the role of human travel and contact tracing in controlling the first wave of COVID-19 in four island nations. Virus evolution. 2021;7(2):veab052.
Heneghan C, Brassey J, Jefferson T. COVID-19: What Proportion Are Asymptomatic? The Centre for Evidence-Based Medicine. [Internet]. [cited 2020 June 4]. Available from: https://www.cebm.net/covid-19/covid-19-what-proportion-are-asymptomatic
Wu Z, McGoogan JM. Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 cases from the Chinese centr for Disease Control and Prevention. JAMA 2020;323(13):1239–42.
CEBM. In patients of COVID-19, what are the symptoms and clinical features of mild and moderate cases? - CEBM. [Internet]. [cited 2020 June 10]. Available from: https://www.cebm.net/covid-19/in-patients-of-covid-19-what-are-the-symptoms-and-clinical-features-of-mild-and-moderate-case/
Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med 2020;383(25):2451–60.
Menni C, Valdes A, Freydin MB, Ganesh S, Moustafa JE, Visconti A, et al. Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection. medRxiv 2020;5:20048421.
Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health 2020;13(5):667–73.
Chow N, Fleming-Dutra K, Gierke R, Hall A, Hughes M, Pilishvili T, et al. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020. MMWR Morb Mortal Wkly Rep 2020;69(13):382–6.
ISS. Characteristics of SARS-CoV-2 Patients Dying in Italy Report Based on Available data on April 16th, 2020. [Internet]. [cited 2020 June 10]. Available from: https://www.epicentro.iss.it/en/coronavirus/bollettino/Report-COVID-2019_16_april_2020.pdf
Center for Disease Prevention and Control (CDC). Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Center for Disease Prevention and Control (CDC). [Internet]. [cited 2020 June 10]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
Watson J, Whiting PF, Brush JE. Interpreting a covid-19 test result. BMJ 2020;369:m1808.
Jaweth N. How is the COVID-19 Virus Detected using Real Time RT-PCR? IAEA. International Atomic Energy Agency 2020.
Woloshin S, Patel N, Kesselheim AS. False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications. N Engl J Med 2020;383(6):e38.
WHO. “Immunity passports” in the context of COVID-19. World Health Organization, 2020. [Internet]. [cited 2020 June 10]. Available from: https://www.who.int/news-room/commentaries/detail/immunity-passports-in-the-context-of-Covid-19
Burki TK. Testing for COVID-19. Lancet Respir Med 2020;8(7):e63–4.
European Centre for Disease Prevention and Control. An overview of the rapid test situation for COVID-19 diagnosis in the EU/EEA. 2020. [Internet]. [cited 2020 June 10]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Overview-rapid-test-situation-for-COVID-19-diagnosis-EU-EEA.pdf
Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA 2020;323(18):1844–4.
Chen Y, Li L. SARS-CoV-2: virus dynamics and host response. The Lancet Infectious Diseases, 2020.
To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020;20(5):565–74.
Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis 2020;20(6):697–706.
CEBM. What clinical features or scoring system, if any, might best predict a benefit from hospital admission for patients with COVID-19? - CEBM. CEBM, 2020. [Internet]. [cited 2020 June 10]. Available from: https://www.cebm.net/covid-19/what-clinical-features-or-scoring-system-if-any-might-best-predict-a-benefit-from-hospital-admission-for-patients-with-covid-19/
WHO. Health Systems Respond to COVID-19 Technical Guidance #2 Creating surge capacity for acute and intensive care Recommendations for the WHO European Region. 2020. [Internet]. [cited 2020 June 10]. Available from: http://www.euro.who.int/__data/assets/pdf_file/0006/437469/TG2-CreatingSurgeAcuteICUcapacity-eng.pdf
Faccincani R, Pascucci F, Lennquist S. How to Surge to Face the SARS-CoV-2 Outbreak: Lessons Learned From Lombardy, Italy. Disaster Med Public Health Prep 2020;14(5):e39–41.
Griffin KM, Karas MG, Ivascu NS, Lief L. Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective. Am J Respir Crit Care Med 2020;201(11):1337–44.
The Lancet. COVID-19: protecting health-care workers. Lancet 2020;395(20):30644–9.
Zhan M, Qin Y, Xue X, Zhu S. Death from Covid-19 of 23 Health Care Workers in China. N Engl J Med 2020;382(23):2267–8.
WHO. Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19). 2020. [Internet]. [cited 2020 June 10]. Available from: https://apps.who.int/iris/bitstream/handle/10665/331498/WHO-2019-nCoV-IPCPPE_use-2020.2-eng.pdf
WHO. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. [Internet]. [cited 2020 June 10]. Available from: https://www.who.int/publications/i/item/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125
Wee LE, Fua TP, Chua YY, Ho AF, Sim XY, Conceicao EP, Venkatachalam I, Tan KB, Tan BH. Containing COVID‐19 in the emergency department: the role of improved case detection and segregation of suspect cases. Academic Emergency Medicine. 2020 May;27(5):379-87.
Chavez S, Long B, Koyfman A, Liang SY. Coronavirus Disease (COVID-19): A primer for emergency physicians. Am J Emerg Med 2020;44:220–9.
European Centre for Disease Prevention and Control. Discharge criteria for confirmed COVID-19 cases – When is it safe to discharge COVID-19 cases from the hospital or end home isolation? European Centre for Disease Prevention and Control. [Internet]. [cited 2020 June 10]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-Discharge-criteria.pdf
Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020;191:9–14.
Kangelaris KN, Ware LB, Wang CY, Janz DR, Zhuo H, Matthay MA, et al. Timing of intubation and clinical outcomes in adults with acute respiratory distress syndrome. Crit Care Med 2016;44(1):120–9.
Brochard L, Lefebvre JC, Cordioli RL, Akoumianaki E, Richard JCM. Noninvasive ventilation for patients with hypoxemic acute respiratory failure. In Thieme Medical Publishers, 2014; p.492–500.
Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med 2017;195(4):438–42.
Rochwerg B, Brochard L, Elliott MW, Hess D, Hill NS, Nava S, et al. Official ERS/ATS clinical practice guidelines: Noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50(2):1602426.
Cinesi Gómez C, Peñuelas Rodríguez Ó, Luján Torné M, Egea Santaolalla C, Masa Jiménez JF, García Fernández J, et al. Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection. Med Intensiva (Engl Ed) 2020;44(7):429–38.
Wang K, Zhao W, Li J, Shu W, Duan J. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China. Ann Intensive Care 2020;10(1):37.
Piva S, Filippini M, Turla F, Cattaneo S, Margola A, De Fulviis S, et al. Clinical presentation and initial management critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Brescia, Italy. J Crit Care 2020;58:29–33.
Alhazzani W, Møller MH, Arabi YM, Loeb Mark, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020;46(5):854–87.
Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000;342(18):1301–8.
Gattinoni L, Chiumello D, Caironi P, Busana M, Federica R, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020;46(6):1099–1102.
Ziehr DR, Alladina J, Petri CR, Maley JH, Moskowitz A, Medoff BD, et al. Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study. Am J Respir Crit Care Med 2020;201(12):1560–4.
Cook TM, El‐Boghdadly K, McGuire B, McNarry AF, Patel A, Higgs A. Consensus guidelines for managing the airway in patients with COVID ‐19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive care Medicine and the Royal College of Anaesthetists. Anaesthesia 2020;75(6):785–99.
van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020;382(16):1564–7.
Cerpa F, Cáceres D, Romero-Dapueto C, Giugliano-Jaramillo C, Pérez R, Budini H, et al. Humidification on Ventilated Patients: Heated Humidifications or Heat and Moisture Exchangers? Open Respir Med J 2015;9:104–11.
Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323(16):1574–81.
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ 2020;368:m1091.
Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 2020;8(5):506–17.
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17(5):259–60.
Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020;38(7):1504–7.
Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med 2020;8(7):738–42.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 2020;97(5):829–38.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–62.
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020;191:145–7.
Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020;18(6):1421–24.
Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020;383(2):120–8.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020;395(10234):1417–8.
Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andrès E. Immune thrombocytopenic purpura in a patient with covid-19. N Engl J Med 2020;382(18):e43.
Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chem Lab Med 2020;58(7):1021–28.
Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol 2020;70(9):311–22.
Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The Cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev 2020;53:25–32.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395(10229):1033–4.
Weston S, Frieman MB. COVID-19: Knowns, Unknowns, and Questions. mSphere 2020;5:e00203–20.
Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis 2020;20(7):773.
Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020;146(1):110–8.
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020;323(18):1824–36.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med 2020;382(19):1787–99.
Wong JC. Hydroxychloroquine: how an unproven drug became Trump’s coronavirus “miracle cure.” The Guardian 2020;7(04):2020.
Mehra MR, Ruschitzka F, Patel AN. Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet 2020;395(10240):1820.
Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med 2020;383(6):517–25.
Beigel JH, Tomashek KM, Dodd LE. Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med 2020;383(10):994.
Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A. Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review. J Med Virol 2020;92(9):1475–83.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
